Impact of First-Line Sildenafil Monotreatment for Pulmonary Arterial Hypertension

Circulation Journal - Japan
doi 10.1253/circj.cj-11-1192
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Circulation Society

Related search

Right Ventricular Reverse Remodelling After Sildenafil in Pulmonary Arterial Hypertension

Heart
Cardiovascular MedicineCardiology
2006English

Current Practices on the Use of Sildenafil Citrate for Pulmonary Arterial Hypertension in Brazilian Hospitals

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2009English

Combining Bosentan and Sildenafil in Pulmonary Arterial Hypertension Patients Failing Monotherapy: Real-World Insights

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2015English

Pulmonary Arterial Hypertension

Current Problems in Cardiology
MedicineCardiovascular MedicineCardiology
2011English

Screening for Pulmonary Arterial Hypertension

Advances in Pulmonary Hypertension
2012English

Sildenafil Inhibits Hypoxia-Induced Pulmonary Hypertension

Circulation
Cardiovascular MedicinePhysiologyCardiology
2001English

Tadalafil Therapy for Pulmonary Arterial Hypertension

Circulation
Cardiovascular MedicinePhysiologyCardiology
2009English

First-Line Drugs for Hypertension

Cochrane Database of Systematic Reviews
2018English

Other Causes of Pulmonary Arterial Hypertension: Pulmonary Veno-Occlusive Disease, Pulmonary Capillary Hemangiomatosis, Porto-Pulmonary Hypertension, HIV- Associated Pulmonary Arterial Hypertension

Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy